Sam Olswanger
🏛️ Revolving DoorFormer Government Positions:
Leg staff, Rep Webster, Jan 11-Jun 11; intrn, Rep Blackburn, Sep 08-Dec 08
Leg staff, Rep Webster, Jan 11-Jun 11; intern, Rep Blackburn, Sep 08-Dec 08
🤖
AI Overview
Sam Olswanger has appeared in 1,269 federal lobbying filings at Akin Gump Strauss Hauer & Feld, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 54 policy areas.
1,269
Total Filings
1
Firms
50
Clients
54
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 53 | 11 |
| 2019 | 76 | 20 |
| 2020 | 110 | 23 |
| 2021 | 127 | 32 |
| 2022 | 143 | 28 |
| 2023 | 241 | 50 |
| 2024 | 251 | 57 |
| 2025 | 268 | 66 |
Firms
Akin Gump Strauss Hauer & Feld1269 filings
Top Clients
Hawkeye 360 INC.87 filings
City of Laredo, Texas72 filings
Emvco, LLC69 filings
Southwest Research Institute41 filings
American Bus Association, INC.39 filings
National Independent Venue Association36 filings
Puerto Rico Statehood Council35 filings
AT&T Services, INC. (FKA AT&T)35 filings
Keidanren28 filings
Hillwood Development Company, LLC26 filings
Doordash26 filings
Altice USA, INC.25 filings
Air Evac Lifeteam23 filings
City of San Antonio23 filings
Stanley Black & Decker, INC.22 filings
Amazon Corporate, LLC21 filings
Garrett Electronics, INC.21 filings
1huddle INC18 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Follow the Money
Tracking lobbying dollars through the financial system.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.